BluGlass (BLG) H2 2025 earnings summary

Executive summary

• Achieved record revenue of $11.7 million, up 16% year-over-year, driven by new development projects and technical milestones in visible GaN lasers across defence, quantum, biotech, and dual-use sectors.

• Expanded project pipeline to 29 active opportunities valued at over US$100 million, including contracts with US Department of Defense, Uviquity, University of Central Florida, and Indian Ministry of Defence.

• Technical achievements included world-record single-mode GaN laser performance and expansion of laser wavelengths, reinforcing competitive positioning.

• Strengthened balance sheet with $7.6 million capital raise and $5.4 million R&D tax rebate; cash receipts from customers increased 216% to $6.9 million.

• Focus remains on converting pipeline opportunities into long-term contracts and scaling laser revenues for sustainable profitability.

Financial highlights

• Revenue increased 16% year-over-year to $11.7 million; consolidated loss for the year rose 8% to $10.98 million.

• Net assets decreased 22% to $11.6 million; cash and cash equivalents at year-end were $5.74 million.

• Laser Diode Project revenue grew 65% to $3.39 million; Laser Diode Product revenue up 476% to $367,560.

• R&D grant income rose 13% to $6.05 million; foundry services revenue declined 32% to $1.69 million.

• Gross expenditure increased 13% to $22.68 million; net cash outflows from operations reduced by 12%.

Outlook and guidance

• Strategic focus on converting US$100 million pipeline into large development contracts and scaling laser orders.

• Four key objectives for FY26: strengthen partnerships, advance technology, improve operations, and win large-scale projects.

• Positioned to capture market share in emerging sectors with few competitors and high barriers to entry.